You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Alcon Laboratories Inc	ROCKLATAN	netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%	70727-529	BENZALKONIUM CHLORIDE	2034-03-14
Alcon Laboratories Inc	ROCKLATAN	netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%	70727-529	BORIC ACID	2034-03-14
Alcon Laboratories Inc	ROCKLATAN	netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%	70727-529	MANNITOL	2034-03-14
Alcon Laboratories Inc	ROCKLATAN	netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%	70727-529	SODIUM HYDROXIDE	2034-03-14
Alcon Laboratories Inc	ROCKLATAN	netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%	70727-529	WATER	2034-03-14
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%

Excipient focus: BENZALKONIUM CHLORIDE

netarsudil and latanoprost ophthalmic solution, 0.02%/0.005% drug variants containing BENZALKONIUM CHLORIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Alcon Laboratories Inc	netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%	70727-529
>Company	>Ingredient	>NDC

netarsudil and latanoprost ophthalmic solution, 0.02%/0.005% drug variants not containing BENZALKONIUM CHLORIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: BORIC ACID

netarsudil and latanoprost ophthalmic solution, 0.02%/0.005% drug variants containing BORIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Alcon Laboratories Inc	netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%	70727-529
>Company	>Ingredient	>NDC

netarsudil and latanoprost ophthalmic solution, 0.02%/0.005% drug variants not containing BORIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MANNITOL

netarsudil and latanoprost ophthalmic solution, 0.02%/0.005% drug variants containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Alcon Laboratories Inc	netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%	70727-529
>Company	>Ingredient	>NDC

netarsudil and latanoprost ophthalmic solution, 0.02%/0.005% drug variants not containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM HYDROXIDE

netarsudil and latanoprost ophthalmic solution, 0.02%/0.005% drug variants containing SODIUM HYDROXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Alcon Laboratories Inc	netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%	70727-529
>Company	>Ingredient	>NDC

netarsudil and latanoprost ophthalmic solution, 0.02%/0.005% drug variants not containing SODIUM HYDROXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

netarsudil and latanoprost ophthalmic solution, 0.02%/0.005% drug variants containing WATER

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Alcon Laboratories Inc	netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%	70727-529
>Company	>Ingredient	>NDC

netarsudil and latanoprost ophthalmic solution, 0.02%/0.005% drug variants not containing WATER

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.